8th International Kawasaki Disease Symposium

第8届国际川崎病研讨会

• 批准号: 6887511
• 负责人: JANE C BURNS
• 金额: $ 3万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-12-01 至 2005-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6887511
• 关键词: cardiovascular disorder diagnosis; cardiovascular imaging /visualization; chemotherapy; diagnosis; disease /disorder etiology; genetic susceptibility; international cooperation; meeting /conference /symposium; mucocutaneous lymph node syndrome; pathologic process; pediatrics; skin disorder diagnosis; travel

DESCRIPTION (provided by applicant): Kawasaki disease (KD) is the most common cause of acquired cardiovascular disease in childhood in the United States. The~ 8th International Symposium will bring together scientists and clinicians from around the world to discuss the latest advances in Kawasaki disease research. The meeting is planned for February 17-20, 2005, in San Diego, California and 400 participants from the U.S. and abroad are anticipated. A major clinical focus of the next meeting will be to review amendments to the clinical case definition proposed by the American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, which are intended to facilitate the timely treatment of all children at risk for coronary artery complications. An international panel of experts will debate the pros and cons of the proposed changes to the clinical case definition. Additional areas of emphasis for this next meeting will include: 1) advances in the understanding of genetic influences on disease susceptibility, response to therapy, and clinical outcome; 2) application of molecular techniques including reverse genetics, epitope library screening, synthetic antibody production, and gene expression analysis by microarray to understand the etiology and pathogenesis of Kawasaki disease; 3) new therapeutic agents for management of acute KD and its chronic cardiovascular complications; and 4) new developments in cardiovascular imaging techniques. These four areas represent rapidly evolving disciplines that will be critical to furthering our understanding of this enigmatic disease. The anticipated audience for this meeting includes pediatric and adult cardiologists; pediatricians and pediatric subspecialists in immunology, infectious disease, and rheumatology; cardiovascular surgeons; pathologists; basic scientists urgenetics, molecular biology, microbiology, cardiovascular pathophysiology; public health officials from county and state agencies and the Centers for Disease Control and Prevention; epidemiologists; and nurses working in the areas of pediatric cardiology and public health.

描述（由申请人提供）：川崎病（KD）是美国儿童获得性心血管疾病的最常见原因。第八届国际研讨会将汇集来自世界各地的科学家和临床医生，讨论川崎病研究的最新进展。该会议计划于 2005 年 2 月 17 日至 20 日在加利福尼亚州圣地亚哥举行，预计将有 400 名来自美国和国外的与会者。下一次会议的临床主要焦点将是审查美国心脏协会风湿热、心内膜炎和川崎病委员会提出的临床病例定义修正案，旨在促进所有有冠心病风险的儿童得到及时治疗动脉并发症。国际专家小组将讨论临床病例定义拟议变更的利弊。下次会议的其他重点领域将包括：1）在理解遗传对疾病易感性、治疗反应和临床结果的影响方面取得进展； 2）应用分子技术，包括反向遗传学、表位库筛选、合成抗体生产、微阵列基因表达分析等，了解川崎病的病因和发病机制； 3）治疗急性川崎病及其慢性心血管并发症的新治疗药物； 4）心血管成像技术的新进展。这四个领域代表了快速发展的学科，对于进一步了解这种神秘疾病至关重要。本次会议的预期观众包括儿科和成人心脏病专家；免疫学、传染病和风湿病学领域的儿科医生和儿科专科医生；心血管外科医生；病理学家；基础科学家泌尿遗传学、分子生物学、微生物学、心血管病理生理学；县和州机构以及疾病控制和预防中心的公共卫生官员；流行病学家；以及在儿科心脏病学和公共卫生领域工作的护士。